Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04750902 · ClinicalTrials.gov registry record · Phase 2

A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children

A Phase 2 study of Dental Caries, sponsored by Colgate Palmolive.

Completed
Registry status
Phase 2
Development phase
2,000
Enrollment target
9
Study locations

NCT04750902: Completed Phase 2 study of Dental Caries, sponsored by Colgate Palmolive.

NCT04750902 is a Phase 2 study of Dental Caries that has completed, run by Colgate Palmolive. The registered enrollment target is 2,000 participants, above the 655-participant average among 30 other Dental Caries trials with a reported enrollment target (205% higher). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04750902, a Phase 2 study of Dental Caries, has completed, sponsored by Colgate Palmolive.

COMPLETED
Registry status
Phase 2
Development phase
2,000 participants
Enrollment target
9
Study locations

Study Summary

The objective of this study is to assess the safety and to evaluate the anti-caries efficacy of COL101 (arginine) non-fluoride dentifrices compared to a 0.24% sodium fluoride dentifrice in 10-14 year-old children over a one year period.

Primary Outcome

The Decayed Missing or Filled Surfaces (DMFS) score is a measure of the extent of dental caries for a subject, defined as the number of scorable tooth surfaces among the up to 128 examined surfaces in the subject's mouth that were determined by the examiner to be decayed, missing, or filled. This score can range between 0 and 128, with higher values indicating a greater level of disease (i.e., worse condition). The Incremental DMFS is defined as the change in DMFS score between two examinations

Conditions Studied

Interventions

  • DRUG 0.24% Sodium Fluoride Dentifrice
  • DRUG 1.5% Arginine Dentifrice
  • DRUG 4.0% Arginine Dentifrice
  • DRUG 8.0% Arginine Dentifrice

Study Locations (9)

Massachusetts

  • Tufts University School of Dental Medicine - Boston
  • The Forsyth Institute - Boston

California

  • Loma Linda University School of Dentistry - Loma Linda

Florida

  • University of Florida College of Dentistry - Gainesville

Indiana

  • Indiana University School of Dentistry - Indianapolis

New York

  • University at Buffalo School of Dental Medicine - Buffalo

Pennsylvania

  • University of Pennsylvania School of Dental Medicine - Philadelphia

Texas

  • UT Health San Antonio School of Dentistry - San Antonio

Other

  • University of Puerto Rico School of Dental Medicine - San Juan

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2021-01-21
Est. Completion 2024-02-29
Phase Phase 2
Colgate Palmolive

51 total trials

What the finished NCT04750902 record still lists

NCT04750902 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 655-participant average among 30 other Dental Caries trials with a reported enrollment target (205% higher).

The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 4 interventions - of which 0.24% Sodium Fluoride Dentifrice is the first listed.

NCT04750902 lists 9 locations in 8 states (Massachusetts, California, Florida).

Frequently Asked Questions

What is clinical trial NCT04750902 about?

NCT04750902 is a clinical study titled "A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children". The objective of this study is to assess the safety and to evaluate the anti-caries efficacy of COL101 (arginine) non-fluoride dentifrices compared to a 0.24% sodium fluoride dentifrice in 10-14 year-old children over a one year period.

What is the current status of trial NCT04750902?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,000 participants. The study started on 2021-01-21. Estimated completion is 2024-02-29.

What conditions does trial NCT04750902 study?

This clinical trial studies the following conditions: Dental Caries.

What interventions are being tested in trial NCT04750902?

The interventions under investigation include: 0.24% Sodium Fluoride Dentifrice (DRUG), 1.5% Arginine Dentifrice (DRUG), 4.0% Arginine Dentifrice (DRUG), 8.0% Arginine Dentifrice (DRUG).

Who is sponsoring clinical trial NCT04750902?

This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04750902 being conducted?

This trial has 9 study locations across California, Florida, Indiana, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04750902's enrollment target sits among peer trials

2,000 4th of 30 higher than 27 of 30 other Dental Caries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dental Caries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04750902, the US trial registry maintained by the National Library of Medicine. NCT04750902 (large enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.